SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-QSB [X] Quarterly Report Under Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Quarter Ended: September 30, 2000 [ ] Transition Report Under Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Transition Period from _____________ to ____________ Commission File Number: 0-26285 ------- AGE RESEARCH, INC. -------------------------------------------------------- (Name of Small Business Issuer in its charter) Delaware 87-0419387 - ------------------------------- ------------------------- (State or other jurisdiction of (I.R.S. Employer I.D. No.) incorporation or organization) 31103 Rancho Viejo Road, #2102, San Juan Capistrano, CA 92675 -------------------------------------------------------------- (Address of principal executive offices and Zip Code) (800) 597-1970 -------------------------------------------------------------- (Registrant's telephone number, including area code) Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. (1) Yes [X] No [ ] (2) Yes [X] No [ ] Indicate the number of shares outstanding of each of the issuer's classes of common stock, as of the latest practicable date. Common Stock, Par Value $0.001 67,259,301 - ------------------------------ ---------------------------- Title of Class Number of Shares Outstanding as of Sepember 30, 2000 ITEM 1. FINANCIAL STATEMENTS AGE RESEARCH, INC. BALANCE SHEET September 30, 2000 and 1999 ASSETS 2000 1999 ----------- ----------- Current Assets Cash $ 1,578 $ 1,239 Accounts Receivable 1,960 2,146 Inventory 2,857 6,460 ----------- ----------- Total Current Assets 6,395 9,845 ----------- ----------- Property and Equipment Furniture and Fixtures 5,560 5,560 Machinery and Equipment 1,794 1,794 ----------- ----------- 7,354 7,354 Less: Accumulated Depreciation (7,231) (6,969) ----------- ----------- Total Property and Equipment 123 385 ----------- ----------- TOTAL ASSETS $ 6,518 $ 10,230 =========== =========== LIABILITIES AND STOCKHOLDERS' EQUITY Current Liabilities Accounts Payable $ 2,993 $ 1,850 Accrued Expense 291 377 Accrued Interest 0 32,220 Income Taxes Payable 0 800 ----------- ----------- Total Current Liabilities 3,284 35,247 ----------- ----------- Long-Term Liabilities Due to Stockholders 0 96,602 ----------- ----------- Total Liabilities 3,284 131,849 ----------- ----------- Stockholders' Equity Common stock, $.001 par value, 100,000,000 shares authorized and 67,259,301 shares issued and outstanding in 2000 and 63,944,251 shares in 1999 67,259 63,944 Paid-in Capital 730,264 600,977 Accumulated Deficit (794,289) (786,540) ----------- ----------- Total Stockholders' Equity (Deficits) 3,234 (121,619) ----------- ----------- TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 6,518 $ 10,230 =========== =========== The accompanying notes are an integral part of these financial statements. AGE RESEARCH, INC. STATEMENT OF INCOME AND ACCUMULATED DEFICIT For the three and nine months ended September 30, 2000 and 1999
Three Months ended Six Months ended September 30, September 30, 2000 1999 2000 1999 ---------- ---------- ---------- ---------- SALES $ 3,863 $ 3,276 $ 11,095 $ 14,880 COST OF SALES 520 880 4,095 4,342 ---------- ---------- ---------- ---------- GROSS PROFIT 3,343 2,396 7,000 10,538 OPERATING EXPENSES 3,092 2,353 9,546 17,596 ---------- ---------- ---------- ---------- INCOME (LOSS) FROM OPERATIONS 251 43 (2,546) (7,058) ---------- ---------- ---------- ---------- OTHER INCOME (EXPENSES) Interest Income 3 0 8 0 Other Income 13 0 178 0 Interest Expenses 0 (1,720) 0 (5,160) ---------- ---------- ---------- ---------- Total Other Income (Expenses) 16 (1,720) 186 (5,160) ---------- ---------- ---------- ---------- INCOME (LOSS) BEFORE TAXES 267 (1,677) (2,360) (12,218) PROVISION FOR INCOME TAXES 0 0 800 800 ---------- ---------- ---------- ---------- NET INCOME (LOSS) 267 (1,677) (3,160) (13,018) ACCUMULATED DEFICITS Beginning Balance (794,556) (784,863) (791,129) (772,210) Prior Year Adjustments 0 0 0 (1,312) ---------- ---------- ---------- ---------- Ending Balance $ (794,289) $ (786,540) $ (794,289) $ (786,540) ========== ========== ========== ========== Net Income (Loss) per share $ 0.00 $ (0.00) $ (0.00) $ (0.00) ========== ========== ========== ========== Weighted Average number of shares 67,259,301 63,944,251 66,154,284 63,944,251 ========== ========== ========== ==========
The accompanying notes are an integral part of these financial statements. AGE RESEARCH, INC. STATEMENTS OF CASH FLOWS For the Nine months ended September 30, 2000 and 1999 2000 1999 ------------- ---------------- CASH FLOWS FROM OPERATING ACTIVITIES Net Income (Loss) $ (3,160) $ (13,018) Adjustment to reconcile net income to net cash provided by operating activities Depreciation 173 269 Prior Year Adjustment 0 (1,312) (Increase) Decrease in: Accounts Receivable 1,301 357 Inventory 4,095 369 Increase (Decrease) in: Accounts Payable (1,623) (799) Accrued Expenses (223) 4,957 Income Taxes Payable 0 0 ------------- --------------- Net Cash Provided (Used) by Operating Activities 563 (9,177) ------------- --------------- CASH FLOWS FROM INVESTING ACTIVITIES 0 0 ------------- --------------- CASH FLOWS FROM FINANCING ACTIVITIES Stockholder subscriptions received 0 7,500 ------------- --------------- Net Cash Provided (Used) by Financing Activities 0 7,500 ------------- --------------- NET INCREASE (DECREASE)IN CASH 563 (1,677) CASH AT BEGINNING OF PERIOD 1,015 2,916 ------------- --------------- CASH AT END OF PERIOD $ 1,578 $ 1,239 ============= =============== SUPPLEMENTARY DISCLOSURES: Cash paid for: Interest Paid $ 0 $ 0 ============= ================ Income Taxes $ 800 $ 1,600 ============= ================ The accompanying notes are an integral part of these financial statements. AGE RESEARCH, INC. NOTES OF FINANCIAL STATEMENTS For The Nine Months ended September 30, 2000 and 1999 NOTE 1 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Presentation of Interim Information - ----------------------------------- In the opinion of the management of Age Research, Inc. (the "Company"), the accompanying unaudited financial statements include all normal adjustments considered necessary to present fairly the financial positions as of September 30, 2000 and 1999, and the results of operations for the three and nine months then ended, and cash flows for the nine months ended September 30, 2000 and 1999. Interim results are not necessarily indicative of results for a full year. The financial statements and notes are presented as permitted by Form 10-QSB, and do not contain certain information included in the Company's audited financial statements and notes for the fiscal year ended December 31, 1999. Use of estimates - ---------------- In preparing financial statements in conformity with GAAP, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and revenues and expenses during the reporting period. Actual results could differ from these estimates. Revenue Recognition - ------------------- Revenue from sales is recognized when the products are shipped. Cash Equivalents - ---------------- For purposes of the statements of cash flows, the Company considers all highly liquid investments with a maturity of three months or less to be cash equivalents. Accounts Receivable - ------------------- Management of the Company considers accounts receivable to be fully collectible, accordingly, no allowance for doubtful accounts is required. If amounts become uncollectible, they will be charged to operations when that determination is made. There was no bad debt expense for neither for 2000 nor 1999. Inventories - ----------- Inventories consist of products already packaged and ready for shipments to customers, and are stated at cost, using the first-in, first-out method. Property and Equipment - ---------------------- Property and Equipment are stated at cost. Depreciation is computed over their estimated useful lives using straight-line method for financial reporting, and accelerated methods for tax reporting, therefore, temporary differences exist. Expenditures for major renewals and betterment that extend the useful lives of the assets are capitalized. Expenditures for maintenance and repairs are charged to expense as incurred. AGE RESEARCH, INC. NOTES OF FINANCIAL STATEMENTS For The Nine Months Ended September 30, 2000 and 1999 NOTE 1 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued) Depreciation expense was $173 and $269 for the nine months ended September 30, 2000 and 1999, respectively. Income Taxes - ------------ The Company accounts income taxes in accordance with Financial Accounting standards Board Statement No. 109. "Accounting For Income Taxes" (SFAS No. 109). SFAS No. 109 requires a company to recognize deferred tax liabilities and assets for the expected future income tax consequences of events that have been recognized in the Company's financial statements. Under this method, deferred tax assets and liabilities are determined based on temporary differences between the financial carrying amounts and the tax bases of assets and liabilities using the enacted tax rates in effect in the years in which the temporary differences are expected to reverse. NOTE 2 - SUBSIDIARY The Company has a wholly-owned subsidiary, Evergreen Skin Care Centers of America, Inc. which is inactive with no assets and liabilities, and has no activity either in 2000 or 1999. NOTE 3 - COMMON STOCK TRANSACTIONS On December 13, 1999, the Board of Directors approved to convert notes payable of $96,602 plus accrued interest of $36,000 into 3,315,050 shares of the Company's common stock. The transaction was recorded as paid-in capital in 1999. In April 2000, all 3,315,050 shares was issued. NOTE 4- GOING CONCERN The accompanying financial statements are presented on the basis that the Company is a going concern. Going concern contemplates the realization of assets and the satisfaction of liabilities in the normal course of business over a reasonable length of time. As shown in the accompanying financial statements, the Company has accumulated deficit of $794,289 as of September 30, 2000, which is due to significant operating losses in past several years. Management is currently involved in active negotiations to obtain additional financing and actively increasing marketing efforts to increase revenues. The Company's continued existence depends on its ability to meet its financial requirements and the success of its future operations. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OR PLAN OF OPERATIONS Results of Operations - --------------------- Since December 1987, the Company has marketed its RejuvenAge products to physicians practicing skin therapy medical specialities. The RejuvenAge products are non-prescription skin care products that do not contain Retin-A or any other precription drug. In addition to the RejuvenAge products, the Registrant sells a proprietary moisturizing shaving cream for sensitive or irritated beard conditions called Bladium. The Company owns the formulations for both the RejuvenAge and Bladium products. The products are manufactured by independent contractors. In order to increase its profitability and reduce expenses, in fiscal 1998 the Company reduced its office expenses to a minimum and eliminated its advertising and salary expenses. Three and Nine Month Periods Ended September 30, 2000 compared to 1999 - ---------------------------------------------------------------------- Revenues and Costs of Sales. For the three month period ended September 30, 2000, the Registrant had revenues of $3,863 with cost of sales of $520, for a gross profit of $3,343, compared to the prior year's revenues for the same period of $3,276 with cost of sales of $880, for a gross profit of $2,396. For the nine month period ended September 30, 2000, the Registrant had revenues of $11,095 with cost of sales of $4,095, for a gross profit of $7,000, compared to the prior year's revenues for the same period of $14,880 with cost of sales of $4,342, for a gross profit of $10,538. The decrease in sales and the decrease in gross profit are directly attributed to reductions in marketing efforts and reduction in cost margins associated with low volume sales. General and Administrative Expense. Total operating expenses for three and nine month periods ended September 30, 2000 and 1999 were $3,092 and $9,546, respectively, compared to $2,353 and 17,596 for the same periods in 1999. The reduction in general and administrative expenses during the recent period is attributed to a reduction in legal and professional fees during the current fiscal year periods as compared to the prior year periods, where the Registrant incurred increased expenses associated the preparing and filing its general form of Registration Statement on Form 10SB with the Securities and Exchange Commission. Net income (loss) for the three and nine month periods ended September 30, 2000 was $267 and $(1,677) respectively, compared to net (loss) of $(3,160) and $(13,018) for the corresponding periods in fiscal year 1999. Liquidity and Capital Resources - ------------------------------- Historically, the Company has financed its operations through a combination of cash flow derived from operations and debt and equity financing. At September 30, 2000, the Company had a working capital surplus of $3,111 based on current assets of $6,518 and current liabilities of $3,284. The Registrant's accompanying financial statements have been presented on the basis that the Company is a going concern because the Registrant has an accumulated deficit of $794,289 at September 30, 2000, which is due to significant operating losses in past several years. The Registrant's management is actively seeking additional financing to increase marketing efforts to increase revenues. Based on its current marketing program and sales, it is clear that the Company will have to increase its sales volume significantly in order to continue operations. At this time, however, the Company does not have any significant working capital to expand its marketing efforts. The Company proposes to finance its needs for additional working capital through some combination of debt and equity financing. Given its current financial condition, it is unlikely that the Company could make a public sale of securities or be able to borrow any significant sum from either a commercial or private lender. The most likely method available to the Company would be the private sale of its securities. There can be no assurance that the Company will be able to obtain such additional funding as needed, or that such funding, if available, can be obtained on terms acceptable to the Company. PART II - OTHER INFORMATION ITEM 1. LEGAL PROCEEDINGS None. ITEM 2. CHANGES IN SECURITIES None. ITEM 3. DEFAULTS UPON SENIOR SECURITIES None. ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS None. ITEM 5. OTHER INFORMATION None. ITEM 6. EXHIBITS AND REPORTS ON FORM 8-K (a) Exhibits. --------- Exhibit 27. Financial Data Schedule (b) Reports on Form 8-K. -------------------- None. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. Age Research, Inc. Dated: November 7, 2000 By:/S/Richard F. Holt, President